March 9, 2014
Short Title: [Revolution in interventional cardiology: the fully bioresorbable vascular scaffold. Presentation]
Alternate Journal: Giornale italiano di cardiologia
ISSN: 1827-6806 (Print)
Original Publication: Rivoluzione nella cardiologia interventistica: lo scaffold coronarico completamente bioriassorbibile. Presentazione.
Accession Number: 24084666
Keywords: *Absorbable Implants
Acute Coronary Syndrome/therapy
*Blood Vessel Prosthesis
Notes: Bolognese, Leonardo
G Ital Cardiol (Rome). 2013 Sep;14(9 Suppl 1):3S. doi: 10.1714/1327.14692.
Reference Type: Journal Article
Record Number: 498Author: Bonetti, P. O.
Title: [Important classifications and scores in cardiology]
Journal: Ther Umsch
Short Title: [Important classifications and scores in cardiology]
Alternate Journal: Therapeutische Umschau. Revue therapeutique
ISSN: 0040-5930 (Print)
Original Publication: Wichtige Stadieneinteilungen und Scores in der Kardiologie.
Accession Number: 24091338
*Decision Support Techniques
*Severity of Illness Index
Abstract: Classifications and scores play a fundamental role in clinical cardiology. While classification systems may help to quantify symptoms and stages of disease, specific scores enable risk stratification and may facilitate decision-making in various cardiac disorders. The present article reviews some of the most frequently used cardiologic classifications and scores. Frequently used classification systems are the NYHA classification for staging patients with cardiac diseases according to their symptoms and functional capacity, and the CCS classification for grading the severity of symptoms in patients with stable angina pectoris. The Killip classification represents a simple clinical tool to estimate mortality risk in patients with acute coronary syndromes. While there is no controversy about the acute management of patients with STEMI – i. e. reperfusion therapy by fibrinolysis or, preferably, primary percutaneous coronary intervention – the diagnostic and therapeutic strategy in patients with NSTE-ACS depends on their individual risk. Various scores have been developed for early risk stratification in patients with NSTE-ACS. Of these, the TIMI risk score and the GRACE score are the most frequently used. Prevention of thromboembolic events represents a primary therapeutic goal in patients with atrial fibrillation. In affected patients, scores such as the CHA2DS2-VASc-Score and the HAS-BLED score are helpful in assessing individual risk of thromboembolic and bleeding complications. Herewith, these scores aid in decision-making for anticoagulation and, thereby, improve prognosis of patients with atrial fibrillation.